Internal Medicine · Honolulu, HI
NPI
1184600504
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
321 N Kuakini St, 703
Honolulu, HI, 96817
Phone (808) 524-4400
Medicare paid, 2024
$73K
885 services
Medicare patients, 2024
194
Average age 77
Drug cost, 2024
$500K
3,174 prescriptions
Company payments, 2024
$14.61
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tad Iwanuma was code 99214 (office e&m - established), 525 times for 191 patients. In total Tad Iwanuma billed 885 services in 10 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 525 | 191 | $85.86 | $45K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 147 | 147 | $135.86 | $20K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 117 | 117 | $20.25 | $2,369 |
| 99213 Office E&M - Established | Office | 39 | 31 | $62.90 | $2,453 |
| 99212 Office E&M - Established | Office | 30 | 25 | $43.67 | $1,310 |
| 99441 Telephone Services | Office | 17 | 17 | $33.73 | $573 |
By year: 2022 $78K for 997 services; 2023 $76K for 939 services; 2024 $73K for 885 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tad Iwanuma prescribed most often to Medicare patients was Atorvastatin Calcium, with 405 prescriptions and refills. In total Tad Iwanuma wrote 3,174 Medicare prescriptions that cost $500K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 405 | 1,212 | 112 | $16K |
| Losartan Potassium Generic | 231 | 689 | 66 | $5,491 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 217 | 650 | 58 | $13K |
| Simvastatin Generic | 214 | 644 | 60 | $6,911 |
| Amlodipine Besylate Generic | 212 | 628 | 59 | $3,847 |
| Metformin Hcl Generic | 119 | 351 | 35 | $1,911 |
| Felodipine Er Felodipine | 115 | 342 | 30 | $5,960 |
| Metoprolol Succinate Generic | 100 | 292 | 26 | $2,208 |
| Jardiance Empagliflozin | 89 | 225 | 21 | $126K |
| Allopurinol Generic | 83 | 249 | 23 | $1,740 |
| Alendronate Sodium Generic | 78 | 218 | 21 | $2,161 |
| Irbesartan Generic | 77 | 231 | 21 | $4,899 |
| Famotidine Generic | 67 | 202 | 20 | $1,898 |
| Olmesartan Medoxomil Generic | 58 | 174 | 17 | $6,856 |
| Levothyroxine Sodium Generic | 58 | 174 | 15 | $201 |
Brand drugs: 329 claims; generic drugs: 2,821 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Tad Iwanuma $14.61 ($14.61 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $14.61.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $14.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.